Open Access

SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

Presentation

About the speaker

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)
26 presentations
0 follower

5 more presentations in this session

Introduction.

Thumbnail

The Power of Per-Protocol Analyses: What Have We Learned from the VEST-Trial?

Speaker: Associate Professor S. Boveda (Toulouse, FR)

Thumbnail

Predictors of Sudden Cardiac Death: What Role Does the Heart Rate Play?

Speaker: Professor J. Sperzel (Bad Nauheim, DE)

Thumbnail

Heart Failure Patient Management: Improved Outcomes for WCD Patients?

Speaker: Professor D. Bondermann (Vienna, AT)

Thumbnail

Discussion and Summary.

Speaker: Professor C. Leclercq (Rennes, FR)

Thumbnail

Access the full session

The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

Speakers: Doctor M. Biffi, Associate Professor S. Boveda, Professor J. Sperzel, Professor D. Bondermann, Professor C. Leclercq
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Pacing in specific conditions.

29 August 2021

Open Access

Challenges in SCD risk stratification.

28 August 2021

ESC Premium Access

Wearable devices and their role in sub-clinical arrhythmia detection.

28 August 2021

This platform is supported by

logo Novo Nordisk